I-Tirezepatide Powder for umjovo yokunciphisa isisindo 30mg nge-vial purrity 99%

I-TirzePatide inoveli, i-anucose-ancike insucose-ancike insulinotropic-insulpeptide (GIP) kanye ne-glucagon-efana ne-peptide-1 (glp-1) i-agonist ye-receptor. Imelela intuthuko ebalulekile ekwelapheni isifo sikashukela sohlobo 2 futhi kukhombisile imiphumela ethembisayo ekuphathweni kwesisindo. I-TirzePatide Imisage powder yifomu lezemithi elisetshenziselwa ukulungiselela isixazululo sokuphatha esingaphansi.

Indlela yokwenza isenzo
I-TirzePatide isebenza ngokwenza kusebenze womabili ama-GIP ne-GLP-1 Receptors, ababambe iqhaza ekulaleni amazinga kashukela wegazi kanye nokudla. I-abonism embaxambili ihlinzeka ngemiphumela eminingana ezuzisayo:

Imfihlo ye-insulin ethuthukisiwe: Ivuselela ukukhishwa kwe-insulin ngendlela ethembele kashukela, isiza ukwehlisa amazinga kashukela wegazi ngaphandle kokubangela i-hypoglycemia.
Ukukhishwa kwe-glucagon okucindezelwe: kunciphisa ukutholakala kwe-glucagon, i-hormone enyukela amazinga kashukela wegazi.
I-Appetite Regulation: Ikhuthaza ukunethemba futhi yehlisa ukudla, okufaka isandla ekunciphiseni isisindo.
Yehlisa i-gastric ukuthulula: kubambezela ukuthulula isisu, okusiza ekulandiseni ama-spikes kashukela e-postprandial.

Ukusetshenziswa okuvunyiwe
Ngokuqondene nezibuyekezo zakamuva, iTirzepatide ivunyelwe yiziphathimandla ezilawulayo ezifana ne-US Food Food and Drug Administration (FDA) zokwelashwa kwesifo sikashukela sohlobo 2. Futhi kungaphansi kophenyo ngokusetshenziswa kwalo okungaba khona ekuphathweni kokukhuluphala.

Izinzuzo
Ukulawulwa okusebenzayo kwe-glycemic: ukuncishiswa okuphambili kumazinga we-HBA1C.
Ukwehla kwesisindo: Ukuncishiswa kwesisindo okukhulu, okuzuzisa iziguli ngesifo sikashukela sohlobo 2 nokukhuluphala.
Izinzuzo zenhliziyo: Ukuthuthuka okungenzeka ezicini zobungozi bezinhliziyo, yize izifundo eziqhubekayo ziqhubeka nokuhlola lesi sici.
Ukusebenziseka lula: I-dosing yake ngeviki ithuthukisa ukubambelela kweziguli uma kuqhathaniswa nemithi yansuku zonke.

Imiphumela emibi engaba khona
Ngenkathi iTirtzepatide ngokuvamile ibekezelelwa kahle, abanye abasebenzisi bangathola imiphumela emibi, kufaka phakathi:

Izinkinga zesisu:

Isicanucanu, ukugabha, isifo sohudo, kanye nokuqunjelwa kuvamile, ikakhulukazi ngesikhathi sokwelashwa.
Ingozi ye-hypoglycemia: ikakhulukazi uma isetshenziswa ngokuhlanganiswa neminye imithi ehlinza ama-glucose.
I-Pancreatitis: akuvamile kodwa kubucayi, kudinga ukunakekelwa kwezokwelashwa ngokushesha uma kunezimpawu ezifana nobuhlungu besisu obukhulu.

Ukulungiselela nokuphatha
I-TirzePatide Distlector powder idinga ukwenziwa kabusha nge-solvent efanelekile (evame ukuhlinzekwa kwikhithi) ukwakha isixazululo somjovo. Isixazululo esakhiwe kabusha kufanele sicace futhi sinamanye izinhlayiya. Iphathwe ngokuqondile esiswini, ithanga noma engalweni engenhla.